Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery

Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery

Purpose: Verteporfin is a benzoporphyrin derivative which is Food and Drug Administration-approved for treatment of choroidal neovascularization in conjunction with photodynamic therapy. It has been shown to prevent fibrosis and scar formation in several organs and represents a promising novel antif...

Full description

Bibliographic Details
Main Authors: Michelle T. Sun, MBBS, PhD, Renee M. Cotton, VMD, Chaow Charoenkijkajorn, MD, Julian Garcia-Sanchez, MD, Roopa Dalal, MSc, Xin Xia, MD, PhD, Jonathan H. Lin, MD, PhD, Kuldev Singh, MD, Jeffrey L. Goldberg, MD, PhD, Wendy W. Liu, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Ophthalmology Science
Subjects:
Antifibrotic
Verteporfin
Glaucoma filtration surgery
Scarring
Rabbit model
Online Access:http://www.sciencedirect.com/science/article/pii/S266691452300180X

Similar Items

Similar Items